| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jan―03 |
Evaluation of the consumption pattern and efficacy of Linezolid in COVID-19 hospitalized patients in a hospital in Tehran-Iran |
Alireza Tavasoli Rostami, Morteza Izadi, Mohsen Saberi, Mehdi Raei, Mostafa Soodmand, Khadijeh Nasiri, Hossein Mardani Nafchi, Mahdi Bagheri |
| 2 |
[GO] |
2024―Jul―19 |
Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication |
Swarnali Das, Sreyashi Nath, Sanjay Kumar Dey |
| 3 |
[GO] |
2024―Apr―23 |
Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach |
Zeinab Dehghan, Seyed Amir Mirmotalebisohi, Maryam Mozafar, Marzieh Sameni, Fatemeh Saberi, Amin Derakhshanfar, Javad Moaedi, Hassan Zohrevand, Hakimeh Zali |
| 4 |
[GO] |
2023―Oct―31 |
Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease |
Gusti Putu Wahyunanda Crista Yuda, Naufa Hanif, Adam Hermawan |
| 5 |
[GO] |
2023―Aug―19 |
COVID-19: A novel holistic systems biology approach to predict its molecular mechanisms (in vitro) and repurpose drugs |
Marzieh Sameni, Seyed Amir Mirmotalebisohi, Sadaf Dadashkhan, Sepideh Ghani, Maryam Abbasi, Effat Noori, Hakimeh Zali |
| 6 |
[GO] |
2023―Aug―19 |
Correction: Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies |
Larissa Toigo, Emilly Isabelli dos Santos Teodoro, Ana Carolina Guidi, Naiara Cássia Gancedo, Marcus Vinícius Petruco, Eduardo Borges Melo, Fernanda Stumpf Tonin, Fernando Fernandez-Llimos, Danielly Chierrito, João Carlos Palazzo de Mello, Daniela Cristina de Medeiros Araújo, Andréia Cristina Conegero Sanches |
| 7 |
[GO] |
2023―May―17 |
Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies |
Larissa Toigo, Emilly Isabelli dos Santos Teodoro, Ana Carolina Guidi, Naiara Cássia Gancedo, Marcus Vinícius Petruco, Eduardo Borges Melo, Fernanda Stumpf Tonin, Fernando Fernandez-Llimos, Danielly Chierrito, João Carlos Palazzo de Mello, Daniela Cristina de Medeiros Araújo, Andréia Cristina Conegero Sanches |
| 8 |
[GO] |
2022―Sep―02 |
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines |
Gelareh Abdolmaleki, Mina Azam Taheri, Sarina Paridehpour, Neshaut Mashreghi Mohammadi, Yasaman Ahmadi Tabatabaei, Taraneh Mousavi, Mohsen Amin |
| 9 |
[GO] |
2022―May―04 |
Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor |
Hemant Suryavanshi, Raju D. Chaudhari, Vishakha Patil, Swapan Majumdar, Sudhan Debnath, Goutam Biswas |
| 10 |
[GO] |
2022―Apr―27 |
West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19 |
Temidayo D. Popoola, Peter A. Segun, Edmund Ekuadzi, Rita A. Dickson, Olanrewaju R. Awotona, Lutfun Nahar, Satyajit D. Sarker, Amos A. Fatokun |
| 11 |
[GO] |
2022―Feb―02 |
Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2 |
Saba Rahimi Bahoosh, Yalda Shokoohinia, Mahdieh Eftekhari |
| 12 |
[GO] |
2022―Jan―27 |
Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: a systematic review and meta-analysis |
Phei Ching Lim, Kar Loon Wong, Retha Rajah, Meng Fei Chong, Ting Soo Chow, Sivasangari Subramaniam, Chong Yew Lee |
| 13 |
[GO] |
2022―Jan―24 |
Calcineurin inhibitors and related medicines: a cohort study examining England’s primary care prescription changes during the COVID-19 pandemic (January 2019 to March 2021) |
Ravina Barrett |
| 14 |
[GO] |
2021―Nov―11 |
Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review |
Pooria Asili, Maryam Mirahmad, Ozra Tabatabaei-Malazy, Azadeh Manayi, Elahe Haghighat, Mohammad Mahdavi, Bagher Larijani |
| 15 |
[GO] |
2021―Mar―13 |
Surging trends in prescriptions and costs of antidepressants in England amid COVID-19 |
Shahad A. Rabeea, Hamid A. Merchant, Muhammad Umair Khan, Chia Siang Kow, Syed Shahzad Hasan |
| 16 |
[GO] |
2020―Aug―28 |
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir |
Hamid Rahmani, Effat Davoudi-Monfared, Anahid Nourian, Morteza Nabiee, Setayesh Sadeghi, Hossein Khalili, Ladan Abbasian, Fereshteh Ghiasvand, Arash Seifi, Malihe Hasannezhad, Sara Ghaderkhani, Mostafa Mohammadi, Mir Saeed Yekaninejad |
| 17 |
[GO] |
2020―Aug―27 |
COVID-19 vaccines: ethical framework concerning human challenge studies |
Daniela Calina, Thomas Hartung, Anca Oana Docea, Demetrios A. Spandidos, Alex M. Egorov, Michael I. Shtilman, Felix Carvalho, Aristidis Tsatsakis |
| 18 |
[GO] |
2020―Aug―18 |
Is there any potential management against COVID-19? A systematic review and meta-analysis |
Haleh Talaie, Sayed Masoud Hosseini, Maryam Nazari, Yadollah Fakhri, Atieh Mousavizadeh, Hossein Vatanpour, Ali Firoozfar |
| 19 |
[GO] |
2020―Aug―15 |
The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19 |
Mohammad Ali Ashraf, Alireza Sherafat, Alieh Pourdast, Pershang Nazemi, Minoo Mohraz |
| 20 |
[GO] |
2020―Jul―30 |
Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection |
Maryam Amini Pouya, Seyyedeh Maryam Afshani, Armin Salek Maghsoudi, Shokoufeh Hassani, Kayvan Mirnia |
| 21 |
[GO] |
2020―Jul―03 |
Short and long term impacts of COVID-19 on the pharmaceutical sector |
Nayyereh Ayati, Parisa Saiyarsarai, Shekoufeh Nikfar |
| 22 |
[GO] |
2020―Jun―25 |
Diabetes management during Ramadan amid Covid-19 pandemic |
Ali Tootee, Ensieh Nasli Esfahani, Bagher Larijani |
| 23 |
[GO] |
2020―Jun―19 |
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study |
Ensieh Vahedi, Mostafa Ghanei, Ali Ghazvini, Hossein Azadi, Morteza Izadi, Yunes Panahi, Saeid Fathi, Mahmood Salesi, Seyed Hassan Saadat, Amir Hossein Ghazale, Mohammad Rezapour, Abolfazl Mozafari, Nahid Zand, Mohammadreza Raesi Parsaei, Mohammad Hossein Ranjkesh, Ramezan Jafari, Fatemeh Movaseghi, Enayat Darabi |
| 24 |
[GO] |
2020―May―08 |
COVID-19 and off label use of drugs: an ethical viewpoint |
Amirahmad Shojaei, Pooneh Salari |
|
